Prudence B. Lam, MD

Clinical Instructor, Department of Medicine, Harvard Medical School

Physician-Investigator, Cancer Biology Program, Beth Israel Deaconess Medical Center

Contact Info

Prudence Lam
Mount Auburn Hospital
330 Mount Auburn St.

Cambridge, MA, 02138
Phone: 617-575-8881
PLam1@caregroup.harvard.edu

Assistant

Maral Banosian
Administrative Assistant
Hematology-Oncology
Cambridge Hospital
1493 Cambridge Street
Cambridge, MA, 02139
Phone: 617-492-0701
mbanosia@mah.harvard.edu

DF/HCC Program Affiliation

Breast Cancer

Research Abstract

My clinical research interest is currently in the field of cancer health disparities and population genetics. In particular, I am interested in the language used in recruiting underserved minorities into clinical trials, their attitudes toward these studies, and how these may impact their participation. Through my translational laboratory research in Her2 overexpressing breast cancer, I have developed a keen interest in cell signaling, especially downstream of oncogenic Ras and Her2/Neu. I would like to examine the relative effects and efficacy of targeted agents on various ethnic populations with epithelial cancers. Learning more about this would be extremely beneficial in better tailoring our treatments for these individuals.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Prudence B. Lam, MD Clinical Instructor, Department of Medicine, Harvard Medical School Physician-Investigator, Cancer Biology Program, Beth Israel Deaconess Medical Center Contact Info Prudence Lam Mount Auburn Hospital 330 Mount Auburn St. Cambridge, MA, 02138 Phone: 617-575-8881 PLam1@caregroup.harvard.edu Assistant Maral Banosian Administrative Assistant Hematology-Oncology Cambridge Hospital 1493 Cambridge Street Cambridge, MA, 02139 Phone: 617-492-0701 mbanosia@mah.harvard.edu DF/HCC Program Affiliation Breast Cancer Research Abstract My clinical research interest is currently in the field of cancer health disparities and population genetics. In particular, I am interested in the language used in recruiting underserved minorities into clinical trials, their attitudes toward these studies, and how these may impact their participation. Through my translational laboratory research in Her2 overexpressing breast cancer, I have developed a keen interest in cell signaling, especially downstream of oncogenic Ras and Her2/Neu. I would like to examine the relative effects and efficacy of targeted agents on various ethnic populations with epithelial cancers. Learning more about this would be extremely beneficial in better tailoring our treatments for these individuals. Publications View All Publications
Site Map Site Feedback Web Privacy Policy